We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+1.82%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$2.7B
AUM Growth
-$320M
Cap. Flow
-$307M
Cap. Flow %
-11.35%
Top 10 Hldgs %
22.03%
Holding
131
New
4
Increased
13
Reduced
110
Closed
4

Top Buys

Rank Stock Value
1
AXTA icon
Axalta
AXTA
+$20.9M
2
COLD icon
Americold
COLD
+$15.1M
3
HXL icon
Hexcel
HXL
+$14.6M
4
AMTM
Amentum Holdings
AMTM
+$11.1M
5
TROX icon
Tronox
TROX
+$6.36M

Sector Composition

Rank Sector Weight
1 Industrials 25.22%
2 Technology 19.37%
3 Healthcare 14.85%
4 Financials 14.08%
5 Consumer Discretionary 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLWS icon
76
1-800-Flowers.com
FLWS
$250M
$13.8M 0.51%
1,690,604
-215,978
-11% -$1.73M
PTEN icon
77
Patterson-UTI
PTEN
$3.98B
$13.7M 0.51%
1,662,018
-243,740
-13% -$1.96M
CHCT
78
Community Healthcare Trust
CHCT
$523M
$13.5M 0.5%
704,428
-84,119
-11% -$1.53M
COLD icon
79
Americold
COLD
$4.02B
$13.4M 0.5%
+624,859
New +$15.1M
ALE
80
DELISTED
Allete
ALE
$12.7M 0.47%
196,495
-20,653
-10% -$1.33M
IT icon
81
Gartner
IT
$10.1B
$11.5M 0.43%
23,690
-2,731
-10% -$1.41M
ROG icon
82
Rogers Corp
ROG
$2.21B
$10.9M 0.4%
107,092
-10,979
-9% -$1.14M
BBT
83
Beacon Financial Corp
BBT
$2.66B
$10.7M 0.4%
376,057
-37,392
-9% -$1.08M
FFIC
84
DELISTED
Flushing Financial
FFIC
$10.2M 0.38%
714,054
-71,300
-9% -$1.14M
PR
85
Permian Resources
PR
$17.8B
$10.1M 0.37%
700,778
-51,849
-7% -$752K
AMTM
86
Amentum Holdings
AMTM
$5.42B
$10M 0.37%
476,977
+431,299
+944% +$11.1M
CSL icon
87
Carlisle Companies
CSL
$14.3B
$9.98M 0.37%
27,047
-3,135
-10% -$1.37M
JBGS
88
JBG SMITH
JBGS
$818M
$9.77M 0.36%
635,664
-61,600
-9% -$1.03M
TROX icon
89
Tronox
TROX
$932M
$9.58M 0.35%
951,277
+522,412
+122% +$6.36M
INSW icon
90
International Seaways
INSW
$4.76B
$9.13M 0.34%
254,026
-43,986
-15% -$1.87M
EHC icon
91
Encompass Health
EHC
$11B
$8.94M 0.33%
96,769
-8,218
-8% -$807K
ATR icon
92
AptarGroup
ATR
$8.55B
$8.74M 0.32%
55,643
-6,439
-10% -$1.08M
CIEN icon
93
Ciena
CIEN
$53.4B
$8.69M 0.32%
102,492
-7,730
-7% -$555K
MD icon
94
Pediatrix Medical
MD
$2.18B
$8.62M 0.32%
657,040
-62,904
-9% -$868K
RRC icon
95
Range Resources
RRC
$9.38B
$8.45M 0.31%
234,825
-22,275
-9% -$737K
DBI icon
96
Designer Brands
DBI
$307M
$8.43M 0.31%
1,578,554
-155,794
-9% -$872K
CDMO
97
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$8.42M 0.31%
681,999
-84,341
-11% -$966K
HLF icon
98
Herbalife
HLF
$1.29B
$6.89M 0.26%
1,030,031
-99,948
-9% -$743K
SAFE
99
Safehold
SAFE
$1.16B
$6.42M 0.24%
347,616
-43,243
-11% -$940K
WNC icon
100
Wabash National
WNC
$512M
$6.42M 0.24%
374,538
-40,539
-10% -$752K

Similar funds

Aristotle Capital Boston's Q4 2024 Portfolio in Review

As of Q4 2024, Aristotle Capital Boston held 131 positions worth $2.7B, down 11% from $3.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aristotle Capital Boston withdrew a net $307M in Q4 2024, closing 4 positions and reducing 110 holdings. Its most notable exit was Aspen Technology Inc, an estimated $30M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aristotle Capital Boston opened a new position in Axalta worth $19M.

  • Aristotle Capital Boston's largest Q4 2024 buy was Axalta: 555,240 shares worth $19M.
  • Aristotle Capital Boston added most to Amentum Holdings in Q4 2024, an estimated $11.1M increase.
  • Aristotle Capital Boston's biggest Q4 2024 reduction was Baldwin Insurance Group, cutting an estimated $34.9M.
  • Aristotle Capital Boston fully exited Aspen Technology Inc in Q4 2024, selling an estimated $30M.
  • Aristotle Capital Boston's ten largest holdings make up 22% of its $2.7B portfolio in Q4 2024.
  • Aristotle Capital Boston opened 4 new positions and closed 4 in Q4 2024.
  • Aristotle Capital Boston's portfolio value fell 11% quarter-over-quarter to $2.7B.

Based on Aristotle Capital Boston's 13F filing for Q4 2024, filed 14 Feb 2025.